Clinical study on the prevention and treatment of acute altitude sickness by respiratory inhalation drugs

Clinical study on the prevention and treatment of acute altitude sickness by respiratory tract inhalation drugs

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16008441

Enrollment

Unknown

Registered

2016-05-09

Start date

2015-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute altitude sickness

Interventions

1:Budesonide

2: Ventolin

3:Combivent

4:physiological salt solution

Eligibility

Sex/Gender

Male

Age

20 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1) young men aged 21-25 years; 2) the soldiers stationed in the plateau; 3) patients signed informed consent, agreed to participate in the study.

Exclusion criteria

Exclusion criteria: 1) over the past year, there have been a history of high altitude exposure; 2) patients with severe heart, lung, and renal failure; 2) to participate in other clinical trials in 3 months.

Design outcomes

Primary

Measure	Time frame
incidence of a disease;hypertension;pulse;oxygen saturation;	—

Contacts

Public ContactYao Chunyan

The First Affiliated Hospital of Third Military Medical University of Chinese people's Liberation Army

yao_yao24@163.com+86 13896192922

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026